Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/02/031522
CTRI/2021/02/031522
Not yet recruiting
未知

Machine learning in the determination of complete tumor response in patients with significant amount of mucin on MRI after neoadjuvant therapy

Dr Akshay Baheti0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Akshay Baheti
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Dr Akshay Baheti

Eligibility Criteria

Inclusion Criteria

  • •i. Patients with rectal adenocarcinoma who underwent neoadjuvant treatment followed by surgery
  • •ii. Availability of restaging high\-resolution rectal MRI
  • •iii. More than 75% of mucin on tumor on T2WI based on visual assessment

Exclusion Criteria

  • •i. Recurrent rectal cancer
  • •ii. Poor image quality (no high resolution T2WI)
  • •iii. Final pathology not available from the institute

Outcomes

Primary Outcomes

Not specified

Similar Trials

Suspended
Not Applicable
The use of artificial intelligence and mobile health technologies to identify patients at the highest risk of atrial fibrillation (irregular and often abnormally fast heart rate)Atrial fibrillation (AF)Circulatory System
ISRCTN17993837Chelsea and Westminster Hospital NHS Foundation Trust1,800
Not yet recruiting
Not Applicable
Advantage of Artificial Intelligence to detect COVID 19 using Chest X-Ray.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2020/08/027008Institute of Technology and Institute of Pharmacy NIRMA University
Active, not recruiting
Phase 1
Development of an algorithm for identification of responders to short term treatment with esomeprazol (Nexium) in primary care. - PPI Response Trialacid related disease
EUCTR2006-000574-69-DKAstraZeneca A/S
Not yet recruiting
Not Applicable
se of AI in Cardiovascular Risk Prediction.Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
CTRI/2023/07/054781A
Completed
Not Applicable
Data collection for development of a software program to detect pulmonary TB from chest X-Rays
CTRI/2017/09/009722Philips India Limited400